Literature DB >> 11504649

Synthesis and SAR of 3- and 4-substituted quinolin-2-ones: discovery of mixed 5-HT(1B)/5-HT(2A) receptor antagonists.

G McCort1, C Hoornaert, M Aletru, C Denys, O Duclos, C Cadilhac, E Guilpain, G Dellac, P Janiak, A M Galzin, M Delahaye, F Guilbert, S O'Connor.   

Abstract

Quinolin-2-ones bearing a heteroaryl-piperazine linked by a two carbon chain at the 3- or 4-position were synthesised and evaluated as mixed 5-HT(1B)/5-HT(2A) receptor antagonists. Potent mixed antagonists were obtained with thieno[3,2-c]pyridine derivatives. In this series, compound 2.1 (SL 65.0472) proved to be functional antagonist at both the 5-HT(2A) receptor (rat in vivo 5-HT-induced hypertension model) and the 5-HT(1B) receptor (dog in vitro saphenous vein assay).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504649     DOI: 10.1016/s0968-0896(01)00118-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Synthesis of 1,2-dihydro-2-oxo-4-quinolinyl phosphates from 2-acyl-benzoic acids.

Authors:  Xinhua He; Tharcilla Aglio; Jeffrey R Deschamps; Rachita Rai; Fengtian Xue
Journal:  Tetrahedron Lett       Date:  2015-03-11       Impact factor: 2.415

2.  Synthetic studies on perophoramidine and the communesins: construction of the vicinal quaternary stereocenters.

Authors:  Jae Hong Seo; Gerald D Artman; Steven M Weinreb
Journal:  J Org Chem       Date:  2006-11-10       Impact factor: 4.354

3.  Synthesis, characterization, and antimicrobial evaluation of carbostyril derivatives of 1H-pyrazole.

Authors:  Nilesh J Thumar; Manish P Patel
Journal:  Saudi Pharm J       Date:  2011-02-03       Impact factor: 4.330

4.  Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays.

Authors:  Nisha S Sipes; Matthew T Martin; Parth Kothiya; David M Reif; Richard S Judson; Ann M Richard; Keith A Houck; David J Dix; Robert J Kavlock; Thomas B Knudsen
Journal:  Chem Res Toxicol       Date:  2013-05-16       Impact factor: 3.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.